Last Update Time:
19-Mar-2025 16:00:00
ISIN:
INE862Y01015
Sector:
Construction
Symbol:
BANKA
Banka BioLoo Limited
₹85.50
₹-2.27
(-2.59%)
▼
Prev. Close
₹87.77
Open
₹91.00
Close
₹85.94
Range
₹81.23 - ₹89.78
High
₹91.00
Low
₹85.50
Ind. Close
₹0.00
VWAP
₹87.61
The current stock price of Banka BioLoo Limited is ₹85.50, with a target price range between ₹81.23 and ₹89.78. The stock has experienced a price change of ₹-2.27 (-2.59%), reflecting recent market volatility.
Today's opening price was ₹91.00, while the previous close stood at ₹87.77.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Banka BioLoo Limited Price Chart
Banka BioLoo Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 91
- Previous Close Price: 87.77
- Change: 3.23%
- Total Traded Volume: 302
- Total Buy Quantity: 763
- Total Sell Quantity: 2,145
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 81.00 | 11.00 | 0.00 |
| 81.80 | 50.00 | 0.00 |
| 84.10 | 200.00 | 0.00 |
| 84.30 | 300.00 | 0.00 |
| 84.40 | 2.00 | 0.00 |
| 91.00 | 0.00 | 250.00 |
| 91.89 | 0.00 | 300.00 |
| 91.90 | 0.00 | 520.00 |
| 92.00 | 0.00 | 408.00 |
| 94.80 | 0.00 | 30.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 763
Total Sell Quantity: 2145
Shareholding Patterns of Banka BioLoo Limited
Key Trade Statistics of Banka BioLoo Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.17 |
| Traded Value (₹ Cr.) | 0.15 |
| Total Market Cap (₹ Cr.) | 92.97 |
| Free Float Market Cap (₹ Cr.) | 40.40 |
| Impact cost | 1.33 |
| Quantity Traded | 17,314.00 |
| Deliverable Quantity | 7,603.00 |
| % of Quantity to Traded | 43.91 |
| Security VaR | 25.19 |
| Index VaR | N/A |
| VaR Margin | 25.19 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 28.69 |
| Face Value | 10 |
Key Price Statistics of Banka BioLoo Limited
The 52-week high for Banka BioLoo Limited was ₹143.90, recorded on 02-Sep-2024. On the other hand, the 52-week low stands at ₹56.99, with the lowest value recorded on 03-Mar-2025.
The upper band for trading is ₹96.54, and the lower band is ₹78.99. The price band is 10%.
The stock's daily volatility stands at 3.74, while the annualized volatility is 71.45. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (02-Sep-2024) | 143.90 |
| 52 Week Low (03-Mar-2025) | 56.99 |
| Upper Band | 96.54 |
| Lower Band | 78.99 |
| Price Band (%) | 10 |
| Daily Volatility | 3.74 |
| Annualised Volatility | 71.45 |
| Tick Size | 0.01 |
Key Securities Statistics of Banka BioLoo Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 29-Oct-2020 |
| Adjusted P/E | 0 |
| Symbol P/E | 0 |
| Index | NA |
| Macro-Economic Sector | Industrials |
| Sector | Construction |
| Industry | Construction |
| Basic Industry | Civil Construction |
Security Status of Banka BioLoo Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Banka BioLoo Limited
| Subject | Date |
|---|---|
| Price movement | 10-Mar-2025 |
| Price movement | 10-Mar-2025 |
| Clarification - Financial Results | 04-Mar-2025 |
| Copy of Newspaper Publication | 15-Feb-2025 |
| Investor Presentation | 14-Feb-2025 |
| ESOP/ESOS/ESPS | 13-Feb-2025 |
| Giving guarantees/indemnity/ becoming a surety for third party | 13-Feb-2025 |
| Integrated Filing- Financial | 13-Feb-2025 |
Corporate Actions of Banka BioLoo Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 01-Aug-2024 |
| 10 | Annual General Meeting | 18-Sep-2023 |
| 10 | Annual General Meeting | 21-Sep-2022 |
| 10 | Annual General Meeting | 21-Sep-2021 |
Board Meetings of Banka BioLoo Limited
Financial Results of Banka BioLoo Limited
Company Directory of Banka BioLoo Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.bankabio.com | Registered Office | Plot no 11-4-651, A?109 Express Apartment, Lakdi ka Pool | N/A |
| www.bankabio.com | Registered Office | Plot no 11-4-651, A?109 Express Apartment, Lakdi ka Pool | N/A |
| www.bankabio.com | Transfer Agent | Bigshare Services Private Limited 306, Right Wing, Amrutha Ville Opp. Yashodha Hospital, Somajiguda Raj Bhavan Road | HYDERABAD |
| www.bankabio.com | Transfer Agent | Bigshare Services Private Limited 306, Right Wing, Amrutha Ville Opp. Yashodha Hospital, Somajiguda Raj Bhavan Road | HYDERABAD |
Insider Trading of Banka BioLoo Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Namita Sanjay Banka | 0 | Sell |
| 7(2) | Sanjay Banka | 0 | Buy |
| 7(2) | Vinraa Technology LLP | 95 | Sell |
| 7(2) | Vinraa Technology LLP | 95 | Sell |
| 7(2) | Vinraa Technology LLP | 98 | Sell |
| 7(2) | Vinraa Technology LLP | 97.5 | Sell |
| 7(2) | Vinraa Technology LLP | 689520 | Buy |
| 7(2) | Vinraa Technology LLP | 9522000 | Buy |
Annual Reports of Banka BioLoo Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Banka BioLoo Limited | 2023 | 2024 | |
| Banka BioLoo Limited | 2022 | 2023 | |
| Banka BioLoo Limited | 2021 | 2022 | |
| Banka BioLoo Limited | 2020 | 2021 |
Investor Complaints of Banka BioLoo Limited
Event Calendar of Banka BioLoo Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the Un-audited Financial results for the quarter ended on September 30, 2018. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2019 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2019 and other business matters |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and Interim dividend for financial year ended on 31.03.2019 |
| Financial Results | To consider and approve the un-audited financial results for the period ended September 30, 2019 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2020, dividend and other business matters |
| Other business matters | to the approval of members to consider and approve the issue of bonus shares to the members of the company in accordance with applicable provisions of the Listing Regulations including the Securities and Exchange (Issue of Capital and Disclosure Requirement) Regulations, 2009 and recommend the same for the approval of members. |
| Dividend/Bonus/Other business matters | To consider dividend, bonus and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results(both Standalone and Consolidated) for the period ended December 31, 2020 |
| Financial Results | To consider and approve the financial results for the quarter and year ended March 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Other business matters | We wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board ofDirectors ( Board Meeting ) of Banka BioLoo Limited (the "Company") is scheduled to be held on14 February 2022 to, inter alia, consider the proposal of issuance of equity shares of the Company onpreferential basis towards consideration in full, for acquisition of 100% equity shares of a privatelimited company ( target company ) to shareholders of the target company, in accordance with theprovisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and theCompanies Act, 2013, as amended, subject to such regulatory/ statutory approvals/ other approvals, asmay be required.This is to, further, inform you, as intimated to the stock exchange, pursuant to the Code of Conduct forprevention of insider trading (the "Code of Conduct"), framed in accordance with the Securities andExchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time totime, the trading window for dealing in the securities shall remain closed for all connected persons /officers / designated employees / insiders, directors of the Company and immediate relatives of thesepersons, including but not limited to the persons specified in the Company's Code of Conduct, 1s closedand shall remain closed till the end of 48 hours from the conclusion of the Board Meeting, or till theexpiry of 48 hours from the publication of un-audited financial results for the quarter ended 31December 2021, whichever is later.Kindly take the same on record. |
| Fund Raising | Sub: Prior intimation under Regulation 29(1)(d) of the Securities and Exchange Board of India (ListingObligations and Disclosure Requirements) Regulation Proposal to Issue Equity Shares on PreferentialBasisDear Sir/ Madam,We wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board ofDirectors ( Board Meeting ) of Banka BioLoo Limited (the "Company") is scheduled to be held on14 February 2022 to, inter alia, consider the proposal of issuance of equity shares of the Company onpreferential basis towards consideration in full, for acquisition of 100% equity shares of a privatelimited company ( target company ) to shareholders of the target company, in accordance with theprovisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and theCompanies Act, 2013, as amended, subject to such regulatory/ statutory approvals/ other approvals, asmay be required.This is to, further, inform you, as intimated to the stock exchange, pursuant to the Code of Conduct forprevention of insider trading (the "Code of Conduct"), framed in accordance with the Securities andExchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time totime, the trading window for dealing in the securities shall remain closed for all connected persons /officers / designated employees / insiders, directors of the Company and immediate relatives of thesepersons, including but not limited to the persons specified in the Company's Code of Conduct, 1s closedand shall remain closed till the end of 48 hours from the conclusion of the Board Meeting, or till theexpiry of 48 hours from the publication of un-audited financial results for the quarter ended 31December 2021, whichever is later.Kindly take the same on record.Thank you! |
| Financial Results | Dear Sir/ Madam,Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Monday, 14 February 2022, inter alia to consider and approve:Un-audited financial results (both standalone and consolidated) for the quarter ended 31 December 2021 and Limited Review Report thereon as on that date.We request you to take the above on record and disseminate the same on your website. Thank you!For Banka BioLoo Limited |
| Fund Raising | Sub: Prior intimation under Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) RegulationsRef: Intimation given by the company to stock exchange on 9 February, 2022 in terms of regulation 29(d) of SEBI LODR Regulation (Enclosed the same for ready reference).Dear Sir/ Madam,We wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors ( Board Meeting ) of Banka BioLoo Limited (the "Company") is scheduled to be held on 19 February 2022 inter-alia: a) To determine of issue price of equity shares to be issued by the company on preferential basis towards consideration in full, for acquisition of 100% equity shares of a private limited company ( target company ) to shareholders of the Enzotech Solutions Private Limited, a private limited company, incorporated under the Companies Act, 2056, bearing Corporate Identity Number U41000TN2006PTC059620, with its registered office at 4, Kuppusamy Street, Off Old Mahabalipuram Road, Karapakam, Chennai - 600097, in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals/ other approvals, as may be required.b) To fix the date, time place of holding EGM for obtaining shareholders approval for aforesaid preferential issue.This is for your information and recordsThank you! |
| Financial results | Banka BioLoo Limited has informed the Exchange about Board Meeting to be held on 30-May-2022 to consider financial statements for the period ended March 2022 |
| Financial results | Banka BioLoo Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider financial statements for the period ended June 2022 |
| Other business matters | Banka BioLoo Limited has informed the Exchange about Board Meeting to be held on 02-Sep-2022 to consider Other business matters |
| Financial results | Banka BioLoo Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results | To consider and approve the financial results for the quarter and year ended March 31, 2023 |
| Financial Results/Fund Raising/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023, Fund Raising and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results (standalone and consolidated) for the period ended 30 June 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the quarter and half year ended September 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
Share Transfers of Banka BioLoo Limited
Voting Results of Banka BioLoo Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 08-AUG-2024 | AGM | TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE FINANCIAL STATEMENTS AND AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED 31 MARCH 2024, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND THE AUDITORS THEREON. |
| 08-AUG-2024 | AGM | TO APPROVE DISINVESTMENT IN WHOLLY-OWNED SUBSIDIARY. |
| 08-AUG-2024 | AGM | APPROVAL OF RELATED PARTY TRANSACTIONS. |
| 08-AUG-2024 | AGM | RE-APPOINTMENT OF MR. SANJAY KUMAR GANGWAR (DIN: 08153290) AS A NON-EXECUTIVE INDEPENDENT DIRECTOR FOR A SECOND TERM HAVING A TENURE OF 5 YEARS. |
| 08-AUG-2024 | AGM | RE-APPOINTMENT OF MR. AKHILESH KUMAR TRIPATHI (DIN: 05338290) AS EXECUTIVE DIRECTOR OF THE COMPANY, FOR A PERIOD OF 3 YEARS, AND APPROVE THE TERMS AND REMUNERATION OF SUCH APPOINTMENT. |
| 08-AUG-2024 | AGM | RE-APPOINTMENT OF MRS. NAMITA SANJAY BANKA (DIN: 05017358) AS MANAGING DIRECTOR OF THE COMPANY, FOR A PERIOD OF 3 YEARS, AND APPROVE THE TERMS AND REMUNERATION OF SUCH APPOINTMENT. |
| 08-AUG-2024 | AGM | RE-APPOINTMENT OF MR. SANJAY BANKA (DIN: 06732600) AS THE EXECUTIVE CHAIRMAN OF THE COMPANY, FOR A PERIOD OF 3 YEARS, AND APPROVE THE TERMS AND REMUNERATION OF SUCH APPOINTMENT. |
| 08-AUG-2024 | AGM | TO APPROVE THE APPOINTMENT OF STATUTORY AUDITORS FOR A PERIOD OF FIVE CONSECUTIVE YEARS, FROM THE CONCLUSION OF THIS ANNUAL GENERAL MEETING UNTIL THE CONCLUSION OF THE 17TH ANNUAL GENERAL MEETING TO BE HELD IN 2029, AND TO FIX THEIR REMUNERATION. |
| 08-AUG-2024 | AGM | TO APPROVE THE APPOINTMENT OF STATUTORY AUDITORS TO FILL THE CASUAL VACANCY CAUSED BY THE RESIGNATION, APPROVED AND RECOMMENDED IN THE BOARD MEETING HELD ON 4 JULY 2024. |
| 08-AUG-2024 | AGM | TO APPOINT A DIRECTOR IN PLACE OF MR. AKHILESH KUMAR TRIPATHI (DIN: 05338290), WHO RETIRES BY ROTATION, AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT. |
| 25-SEP-2023 | AGM | TO CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENTS (BOTH STANDALONE AND CONSOLIDATED) OF THE COMPANY FOR THE FINANCIAL YEAR ENDED 31 MARCH 2023, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND THE AUDITORSￂ THEREON |
| 25-SEP-2023 | AGM | To approve grant of Employee Stock Options equivalent to or exceeding 1% of the Issued Share Capital of the Company |
| 25-SEP-2023 | AGM | To approve grant of Options under the ￂBanka BioLoo Limited Employees Stock Option Plan - 2023ￂ (ￂPlanￂ or ￂESOP 2023ￂ or ￂSchemeￂ) to the eligible employees of the Subsidiary Companies of the Company |
| 25-SEP-2023 | AGM | To approve the ￂBanka BioLoo Limited Employees Stock Option Plan - 2023ￂ (ￂPlanￂ or ￂESOP 2023ￂ or ￂSchemeￂ) |
| 25-SEP-2023 | AGM | To appoint a Director in place of Ms. Namita Banka (DIN: 05017358), who retires by rotation, and being eligible, offers herself for re-appointment |
| 29-SEP-2022 | AGM | Ordinary - TO CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENTS (BOTH STANDALONE AND CONSOLIDATED) OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2022, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND THE AUDITORSￂ THEREON |
| 29-SEP-2022 | AGM | Special - Re-appointment of Mr. Vishal Murarka as Executive Director, designated as Chief Executive Officer (CEO) of the Company for a period of 3 years. |
| 29-SEP-2022 | AGM | Special - Appointment of Mr. Anil Sharma (DIN 09490844) as a Non-Executive Independent Director of the Company, for a term of 5 years |
| 29-SEP-2022 | AGM | Ordinary Resolution - Re-Appointment of statutory auditors and fix their remuneration |
| 29-SEP-2022 | AGM | Ordinary - To appoint a director in place of Mr. Vishal Murarka (DIN: 06729485), who retires by rotation and being eligible, offers himself for re-appointment |
FAQs on Banka BioLoo Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.